How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?

ABSTRACT:

Objectives

Investigating men's perceived lifetime risk of prostate cancer.

Design

Survey-based study to men invited for prostate-specific antigen (PSA) screening in the GÖTEBORG-2 trial between September 2015 and June 2020.

Setting

38 775 men in the Gothenburg area, Sweden, were invited for PSA-testing and participated in a survey.

Participants

17 980 men participated in PSA-testing, of whom 13 189 completed the survey. In addition, 1264 men answered the survey only.

Interventions

Before having the PSA-test, men answered an electronic survey and estimated their lifetime risk of receiving a prostate cancer diagnosis on a visual analogue scale from 0% to 100%.

Main outcome measures

The primary outcome was the median lifetime risk estimation, which w

SUBMITTER: Palmstedt E 

PROVIDER: S-EPMC11331866 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature